| 卡培他滨在进展期结直肠癌治疗中医疗成本的分析 |
| |
| 引用本文： | 陈宇萍,胡善联.卡培他滨在进展期结直肠癌治疗中医疗成本的分析[J].中国药房,2004,15(7):415-416. |
| |
| 作者姓名： | 陈宇萍 胡善联 |
| |
| 作者单位： | 复旦大学公共卫生学院,上海市,200032 |
| |
| 摘 要： | 目的 :评价卡培他滨在进展期结直肠癌治疗中的医疗成本。方法 :比较卡培他滨与经典MAYO方案在临床疗效和医疗费用方面的特点。结果与结论 :卡培他滨价格较传统药物贵 ,但从医疗资源角度看 ,应用卡培他滨节省的医疗成本最大限度地抵消了药价的成本 ,其医疗成本优于传统药物。
|
| 关 键 词： | 卡培他滨 结直肠癌 医疗成本 |
| 文章编号： | 1001-0408(2004)07-0415-02 |
| 修稿时间： | 2004年6月26日 |
Analysis of the Medical Cost of Capectabine in Treatment of Advanced Rectocolonic Carcinoma |
| |
| CHEN Yuping,HU Shanlian.Analysis of the Medical Cost of Capectabine in Treatment of Advanced Rectocolonic Carcinoma[J].China Pharmacy,2004,15(7):415-416. |
| |
| Authors: | CHEN Yuping HU Shanlian |
| |
| Abstract: | OBJECTIVE:To evaluate the medical cost of capectabine in treatment of advanced rectocolonic carcinoˉma.METHODS:The characteristics of therapeutic effect and medical cost were compared between capectabine and classical MAYO program.RESULTS&CONCLUSION:The capectabine is more expensive than traditional drugs,however,in terms of medical resource,the saving medical cost in use of capectabine would counterbalance the expensive price of drug to maxium limit.The medical cost of capectabine is superior to that of traditional drugs. |
| |
| Keywords: | capectabine rectocolonic carcinoma medical cost |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
